CMS Boosts Medicare Payments for High-Throughput COVID-19 Diagnostic Tests
04/16/2020
The Trump administration will nearly double payments for high-throughput technology that can rapidly test and diagnose COVID-19 cases, according to a FierceHealthcare report.
The Centers for Medicare & Medicaid Services’ (CMS’) action announced Wednesday comes as experts call for a major increase in testing in order to reopen the economy.
The agency said Medicare will pay a higher payment of $100 for COVID-19’s clinical diagnostic lab tests that use “high-throughput technologies developed by the private sector that allow for increased testing capacity, faster results and more effective means of combating the spread of the virus.”